Hands-on training in the field’s newest approaches and technologies will be supported at NJIT’s labs and at The New Jersey Innovation Institute’s Cell and Gene Therapy Development Center. NJII says the center will upgrade the knowledge and skills of bio-pharmaceutical professionals in the processing of new, breakthrough classes of biologic therapies.
Both programs were developed to meet growing demands from the bio-pharmaceutical industry for trained scientists and engineers at the forefront of the coming wave of breakthrough gene and cell therapies, including advanced gene delivery technologies to immunotherapies such as CAR-T cancer therapy.